Aveanna Healthcare Reports Strong Q3 2026 Results with Raised Full-Year Guidance
Aveanna Healthcare (AVAH) reported robust third-quarter 2026 financial results, highlighted by an 11.8% increase in revenue to $695.5 million and a 25% surge in adjusted EBITDA to $100.1 million. Growth was driven across all three operating segments: Private Duty Services (PDS), Home Health and Hospice (HHH), and Medical Solutions (MS). The company's strategic shift toward preferred payer agreements has successfully improved revenue per hour and patient, while operational efficiencies have bolstered cash flow. Following these results, management raised its full-year 2026 guidance for both revenue and adjusted EBITDA. Long-term organic growth targets were also revised upward for the PDS and HHH segments. Despite strong performance, leadership noted potential headwinds regarding permanent wage increases in California and a non-recurring 14th week in the prior year's fourth quarter that may impact sequential comparisons.
Tickers: $AVAH
Topics: EBITDA home health and hospice medical solutions private duty services revenue growth